First identify what was denied
A vitamin D blood assay is a service used to investigate or monitor a health concern. A prescription or over-the-counter vitamin product is a different item. The CMS policy discussed here concerns assay testing; it cannot establish the coverage of a bottle of supplements or every prescription formulation. [1]
Screening and diagnostic testing can be treated differently
CMS local policy L33996 lists medical indications for vitamin D testing and states that routine screening is not covered under that policy. Relevant indications include specified bone, kidney, absorption and deficiency-monitoring circumstances. A request simply to check a level without a documented indication can therefore be handled differently from testing for an established clinical concern. [1]
Repeat tests also need a reason
The policy limits additional testing after deficiency is identified to establishing adequate replacement, with later testing dependent on the indication and circumstances. That does not create automatic coverage for unlimited repeat measurements. The treating clinician and billing team should describe the actual reason accurately. [1]
This example is local, not universal
The inspected L33996 revision took effect August 6, 2026 and identifies CGS contracts for Kentucky and Ohio. Other Medicare contractors, private plans and service dates may have different rules. Use the policy applicable to the claim rather than assuming that this example determines every patient’s benefits. [1]
Make the follow-up specific
Imagine a bill says a screening assay was denied even though the clinician was monitoring documented deficiency. Ask the billing office and insurer to review the service, documentation and stated denial reason. If the denied item was a vitamin product instead, ask about the applicable product benefit or formulary; this assay policy does not answer that separate question. [1]
| Detail | Why it matters |
|---|---|
| Test or vitamin product | Different claim types |
| Screening or diagnostic reason | May change medical-necessity assessment |
| Service date and plan | Determines applicable policy |
| Written denial reason | Identifies the issue to review |
Sources for this article
- LCD - Vitamin D Assay Testing (L33996)
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.